Overview
A study evaluating Obicetrapib in adults potentially at risk for Preclinical Alzheimer's Disease
Eligibility
Inclusion Criteria:
- participants with preclinical AD
Exclusion Criteria:
- APOE genotype not meeting protocol-defined eligibility criteria


